COMP <GO>
HON vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Honeywell International Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HON 8
— TMO 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: HON
LAST: $218.33 (-1.72%) • MKT CAP: $70.50B
roic
38.90%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HON VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HON | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | 41.00% | -4.10 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 38.90% | 9.30% | +29.60 | HON | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.2x | 30.4x | -22.20 | HON | /valuation <GO> |
| Free Cash Flow Yield | 7.69% | 2.40% | +5.29 | HON | /fcf-yield <GO> |
| Operating Margin | 21.70% | 17.40% | +4.30 | HON | /operating-margins <GO> |
| Net Profit Margin | 12.60% | 15.10% | -2.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.80% | 3.90% | +3.90 | HON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.22% | 0.24% | +3.98 | HON | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.15 | 4.50 | -1.35 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.9 | 59.1 | -2.28 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | HON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.9x | 36.3x | -22.40 | HON | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.50B | $262.22B | -$191.72B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HON REV | TMO REV | HON GROSS % | TMO GROSS % | HON FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $37.44B | $44.56B | 36.9% | 44.0% | $5.42B | $6.29B |
| FY 2024 | $34.72B | $42.88B | 38.5% | 44.0% | $5.23B | $7.27B |
| FY 2023 | $33.01B | $42.86B | 44.0% | 44.0% | $3.85B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HON // BETA 1.01
TMO // BETA 0.94